Answers are grounded in this paper and cite their sources.
Treatment with S. boulardii CNCM I-745 prevents diclofenac-induced enteropathy through anti-inflammatory and antioxidant activities. Such effects are likely to be related to increased tissue butyrate bioavailability, through an improvement of butyrate uptake by the enteric mucosa.
No takes yet. Share an insight, caveat, or question.
D’Antongiovanni et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: